Biotech · Private company
Outpace Bio, Inc.
Track this companyFree. Adds Outpace Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- OPB-101Phase 1 · Ovarian Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- OPB-201Phase 1 · Endometrial Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.PHASE1 · RECRUITING · started Jun 30, 2026ClinicalTrials.gov NCT07664735 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian CancerPHASE1 · TERMINATED · started Jun 16, 2025ClinicalTrials.gov NCT07030907 · fetched Nov 12, 2026